
Seeing double: Designing drugs that target twin cancer proteins Scripps Research scientists used knowledge about a protein to characterize drugs that selectively bind to its twin, or paralog.
September 30, 2024
LA JOLLA, CA Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, with no clear drug-binding sites.
To design a drug that blocks a cancer-related protein, Scripps Research scientists took a hint from the protein's paralog, or twin. Using innovative chemical biology methods, the scientists pinpointed a druggable site on the paralog, and then used that knowledge to characterize drugs that bound to a similar but more difficult to detect spot on its twin. Ultimately, they found drugs that only bound to the protein of interest and not its highly similar sibling.
Their approach, described in Nature Chemical Biology on September 18, 2024, and dubbed paralog hopping, could uncover new binding sites for drugs and inform drug development more broadly, since nearly half of the proteins in human cells including many involved in cancer and autoimmune diseases have such paralogs.
This method may be generally useful in cases where you have paralogs, and you are trying to find a new drug for one of them, says senior author Benjamin Cravatt, PhD, the Norton B. Gilula Chair in Biology and Chemistry at Scripps Research. Being able to target one paralog over another is an important goal in drug development, as two paralogs often have different functions.
Many genes have duplicated throughout evolution, resulting in multiple copies in the human genome. In some cases, copies have evolved slightly different sequences from each other, making their corresponding proteins into paralogs. These protein paralogs remain highly similar in structure and often have redundant or overlapping functions within cells.
In recent years, Cravatt's research team formulated an approach to develop drugs that bind to the amino acid cysteine a protein building block with unique, highly reactive chemical properties. The scientists' method takes advantage of cysteines as an optimal site for drugs to attach to a protein permanently, often inactivating it. However, not all proteins have accessible cysteines. In the cases of paralog pairs, one protein may have a druggable cysteine that the other does not.
We started with this idea that if you know how to drug one protein, you can figure out how to drug its paralog in a similar way, says Yuanjin Zhang, a graduate student at Scripps Research and first author of the new paper.
As a test case, the team tackled the paralog pair known as CCNE1 and CCNE2. Both proteins have been found to be overactive in breast, ovarian and lung cancer. However, scientists suspected that the two proteins play slightly different roles. The team posited that turning off just one protein could make treating some cancers more effective.
It has been difficult, however, to design drugs that target the CCNE1 and CCNE2 proteins to test this hypothesis. Cravatt, Zhang and their colleagues knew that CCNE2 had a druggable cysteine, while CCNE1 did not. If they could identify drugs that bound to the same spot on CCNE1, even in the absence of a cysteine, they suspected the protein would shut off.
The scientists first engineered a cysteine into CCNE1, mimicking the drug-binding spot they had pinpointed in CCNE2. They then leveraged this neo-cysteine to identify drugs that bind to CCNE1. Next, they screened a library of other chemical compounds for the ability to compete with that drug in binding to CCNE1. The team reasoned that some of the compounds that competed for the same spot would bind in ways that did not rely on the cysteine.
Indeed, Cravatt, Zhang and their colleagues discovered multiple compounds that could bind to the same site on CCNE1 even when the cysteine was removed again. Some compounds did not bind to CCNE2. Some also had opposite functions, stabilizing the molecule so that it might be more active than usual, rather than inactivating it. Structural studies revealed that the CCNE1 compounds bind to a cryptic pocket that was not previously known to be druggable.
The team says the approach highlights the importance of screening for drugs in diverse, creative ways.
If we had just screened looking for compounds with a particular function, we would not have identified all of these various functional molecules, and if we had just looked at the structure of CCNE1, we would not have found this binding pocket at all, says Zhang.
More research is needed to discover whether the new compounds have potential utility in treating cancer or other diseases in which CCNE1 plays a role. Next, the scientists plan to apply their paralog-hopping method to other pairs of proteins important for tumorigenesis.
In addition to Cravatt and Zhang, authors of the study, An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes, include Zhonglin Liu, Sang Joon Won, Divya Bezwada and Bruno Melillo of Scripps Research; and Marsha Hirschi, Oleg Brodsky, Eric Johnson, Asako Nagata, Matthew D. Petroski, Jaimeen D. Majmudar, Sherry Niessen, Todd VanArsdale, Adam M. Gilbert, Matthew M. Hayward, Al E. Stewart and Andrew R. Nager of Pfizer, Inc.
This work was supported by funding from the National Cancer Institute (R35 CA231991) and Pfizer.
Chemistry Cravatt, Benjamin
North America Stories
08/04/2026
The deadline to enter the 18th Annual SVG College Sports Media Awards in association with NACDA is rapidly approaching! Submit your entries to this year's c...
08/04/2026
The Pittsburgh product helps lead more than 100 annual ESPN broadcasts as part o...
08/04/2026
Dynamic ad insertion, AI-based technologies, programmatic advertising are some o...
08/04/2026
Seven Fellows Selected for Second Year of Residency in Honor of Social Justice L...
08/04/2026
The September 19, 2025 YEP Newsletter highlights a group visit to the Academy Museum of Motion Pictures, where participants explored exhibits showcasing the art...
08/04/2026
The L3Harris HBTSS satellite is proven on orbit, successfully demonstrating trac...
08/04/2026
Image Credit: NASA. Artist rendering of a space communications satellite in orbit, representative of the resilient, multiband infrastructure supporting mission ...
08/04/2026
Latest evaluation validates image quality, Inertial Navigation System performance and long-range tracking in operational flight conditions....
08/04/2026
New Gracenote study finds behavioral change well underway, but trust in AI-gener...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Integration eliminates ingest bottlenecks by ensuring content is immediately usable across cloud and hybrid editorial workflows. See it at NAB 2026.
Nevada Cit...
08/04/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the commercial availability of Dalia, its media-aware, agentic AI...
08/04/2026
Leading video software provider Synamedia today announced Senza Ignite, a cloud-based platform that transforms existing connected devices through a single firmw...
08/04/2026
Modernised architecture increases operational control and agility, while reducing cost and simplifying nationwide media transport across affiliates and news bur...
08/04/2026
Company to Feature DMX Dual Relay, High-Density 48-Channel Relay Panels, and New Private Label Power Program
LynTec, a leading manufacturer of innovative ele...
08/04/2026
Broadcasting Center Europe (BCE), a European media technology and services partner, today announces a technology partnership with BCNEXXT, a Netherlands-based c...
08/04/2026
Encompass Digital Media today announced the expansion of its Master Control Room (MCR) facility in Riga, Latvia, establishing it as one of the most advanced and...
08/04/2026
Leading video solutions provider Synamedia is back at The 2026 NAB Show with innovations that connect tomorrows audiences today. On display will be a range of t...
08/04/2026
COW Jobs: Director Needed for WWII Indie Docudrama
Brie Clayton April 8, 2026
0 Comments
Director Needed for WWII Indie Docudrama
March 17, 2026COW ...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/04/2026
Marshall Electronics introduces its latest POV camera with the new CV376 Compact NDI |HX3 HDMI POV Camera at NAB 2026 (Booth C8339). Designed for versatile 4K c...
08/04/2026
Zixi, a leader in live video delivery and workflow orchestration, enables interoperable live video workflows across multi-vendor environments, helping broadcast...
08/04/2026
Back to All News
Agent from Above' Celebrates Divine Ascent to Global Rank...
08/04/2026
Back to All News
Official Poster Revealed for My Two Cents, the New Animated Se...
08/04/2026
Scripps Research scientists uncover new mechanism cancer cells use to survive DNA damage Discovery reshapes understanding of how tumor cells repair broken DNA, ...
07/04/2026
Ikegami USA will launch a refinement to the UHK-X700 and UHK-X750 3-CMOS -in. UHD cameras in the UNICAM XE series plus two new 7-in. viewfinders at NAB 2026 in...
07/04/2026
The NAB Leadership Foundation and NAB PILOT will host a career mixer for technology students at NAB Show 2026 on April 18, 5-6:30 p.m., North Hall, Room N225/22...
07/04/2026
Audinate Group Limited and Futuresource Consulting have published results from a...
07/04/2026
Eluvio has announced the commercial availability of its Content Fabric Bucharest...
07/04/2026
Eluvio has unveiled a new architecture for video AI and an updated Eluvio Video Intelligence Editor (EVIE) ahead of NAB Show 2026. Eluvio AI runs analysis and i...
07/04/2026
The Professional Fighters League (PFL) has announced a deal with Sky New Zealand...
07/04/2026
The NBA and Enjoy Basketball, the digital media company co-founded by YouTube cr...
07/04/2026
The 4,000-sq.-ft. space in Frisco, TX, has produced live and packaged programmin...
07/04/2026
What began as a referee training tool is evolving into a powerful production ass...
07/04/2026
Manifold Technologies will announce at NAB Show 2026 (Booth C.1808) that its manifold CLOUD platform will be available as a deployable application within NEP Pl...
07/04/2026
Shaquille O'Neal, Authentic Brands Group, and TNT Sports, in partnership wit...
07/04/2026
Telos Alliance will debut the Omnia XII, a new FM/HD/DAB audio processor, at NAB Show 2026 in Las Vegas.
Built on a 2RU hardware platform, Omnia XII features a...
07/04/2026
Amazon Web Services (AWS) will exhibit at NAB Show 2026 (April 18-22, Las Vegas Convention Center, Booth W1701), with demonstrations, speaking sessions, and int...
07/04/2026
Synamedia will demonstrate AI by Quortex at NAB Show 2026, a framework that applies AI capabilities to video workflows on demand rather than continuously. The s...
07/04/2026
TVNewsCheck will present its 15th annual Women in Technology Awards on Tuesday, April 21, at 5 p.m. PT at NAB Show, in the Media and Entertainment Theater (W146...
07/04/2026
Akta will demonstrate its AI video platform at NAB Show 2026, highlighting new capabilities in media processing and vertical video formatting alongside its exis...
07/04/2026
ESPN and Disney have announced the launch of ESPN on Disney in Europe and select Asia-Pacific markets, bringing the offering to 53 countries and territories a...
07/04/2026
LOS ANGELES, CA, April 7, 2026 - The nonprofit Sundance Institute announced today the fellows selected for the 2026 Native Lab, the signature initiative of the ...
07/04/2026
The November 2025 YEP Newsletter highlights a recent YEP Coffee Chat, offering members the chance to connect with industry professionals in an informal setting ...
07/04/2026
The December 2025 YEP Newsletter includes a Spotlight on Emily Vail, showcasing her career journey and work in the industry, alongside Mentorship Reflections by...